1. Home
  2. CSPI vs PMN Comparison

CSPI vs PMN Comparison

Compare CSPI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$9.17

Market Cap

107.1M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.43

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
PMN
Founded
1968
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.1M
115.5M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
CSPI
PMN
Price
$9.17
$11.43
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
11.9K
34.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
1.32%
N/A
EPS Growth
75.00
N/A
EPS
0.01
N/A
Revenue
$58,730,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$908.00
N/A
Revenue Growth
6.36
N/A
52 Week Low
$7.55
$0.29
52 Week High
$17.76
$27.40

Technical Indicators

Market Signals
Indicator
CSPI
PMN
Relative Strength Index (RSI) 55.11 35.71
Support Level $8.89 $10.57
Resistance Level $9.09 $19.85
Average True Range (ATR) 0.54 1.36
MACD 0.12 -0.02
Stochastic Oscillator 61.57 20.68

Price Performance

Historical Comparison
CSPI
PMN

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: